PARATEK PHARMACEUTICALS INC's ticker is PRTK and the CUSIP is 699374302. A total of 68 filers reported holding PARATEK PHARMACEUTICALS INC in Q2 2015. The put-call ratio across all filers is - and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $1,327,000 | -52.3% | 101,966 | -49.0% | 0.12% | -63.5% |
| Q2 2016 | $2,782,000 | +104.9% | 200,000 | +123.4% | 0.34% | +82.2% |
| Q1 2016 | $1,358,000 | -49.4% | 89,531 | -36.7% | 0.18% | -28.8% |
| Q4 2015 | $2,682,000 | +4.0% | 141,367 | +4.2% | 0.26% | +15.6% |
| Q3 2015 | $2,578,000 | -28.5% | 135,710 | -3.1% | 0.22% | -12.1% |
| Q2 2015 | $3,607,000 | – | 140,000 | – | 0.26% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AIGH Capital Management LLC | 2,339,107 | $10,502,000 | 3.20% |
| Telemetry Investments, L.L.C. | 262,279 | $1,178,000 | 1.52% |
| Bruce & Co., Inc. | 1,443,312 | $6,480,000 | 1.30% |
| Omega Fund Management, LLC | 1,971,241 | $8,851,000 | 1.25% |
| Worth Venture Partners, LLC | 556,832 | $2,500,000 | 1.24% |
| Abingworth LLP | 1,041,131 | $4,654,000 | 1.13% |
| 1492 Capital Management LLC | 491,033 | $2,205,000 | 1.09% |
| CM Management, LLC | 300,000 | $1,347,000 | 1.02% |
| Trellus Management Company, LLC | 295,000 | $1,325,000 | 0.88% |
| GENERAL AMERICAN INVESTORS CO INC | 1,306,919 | $5,868,000 | 0.46% |